Â. Fêde

1.2k total citations
28 papers, 917 citations indexed

About

Â. Fêde is a scholar working on Surgery, Oncology and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Â. Fêde has authored 28 papers receiving a total of 917 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Surgery, 7 papers in Oncology and 6 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Â. Fêde's work include Head and Neck Surgical Oncology (3 papers), Cancer Treatment and Pharmacology (3 papers) and Pharmacological Effects and Toxicity Studies (3 papers). Â. Fêde is often cited by papers focused on Head and Neck Surgical Oncology (3 papers), Cancer Treatment and Pharmacology (3 papers) and Pharmacological Effects and Toxicity Studies (3 papers). Â. Fêde collaborates with scholars based in Brazil, Italy and Belgium. Â. Fêde's co-authors include Auro del Giglio, C. Marchiori, Antonio Jirillo, Antonio Orlando, L. Tomio, G Cavaniglia, Rachel P. Riechelmann, Vanessa da Costa Miranda, P. L. Zorat and Adriano Paccagnella and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and JNCI Journal of the National Cancer Institute.

In The Last Decade

Â. Fêde

25 papers receiving 889 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Â. Fêde Brazil 11 454 441 322 226 102 28 917
Yimei Han United States 17 346 0.8× 61 0.1× 499 1.5× 358 1.6× 10 0.1× 49 1.1k
Ronald J. Maggiore United States 21 149 0.3× 121 0.3× 532 1.7× 330 1.5× 521 5.1× 46 1.2k
Trine Lembrecht Jørgensen Denmark 12 120 0.3× 15 0.0× 409 1.3× 156 0.7× 194 1.9× 41 764
Raymond Jang Canada 19 120 0.3× 33 0.1× 158 0.5× 128 0.6× 102 1.0× 44 768
C Proudlove United Kingdom 11 60 0.1× 40 0.1× 99 0.3× 126 0.6× 28 0.3× 15 466
Cheryl Silberman United States 7 86 0.2× 30 0.1× 250 0.8× 280 1.2× 9 0.1× 10 736
C McLeod United Kingdom 16 123 0.3× 43 0.1× 134 0.4× 178 0.8× 8 0.1× 27 835
Goulnar Kasymjanova Canada 18 68 0.1× 31 0.1× 575 1.8× 501 2.2× 33 0.3× 56 1.0k
Anne Marie C. Flaherty United States 5 763 1.7× 9 0.0× 225 0.7× 112 0.5× 13 0.1× 10 1.0k
C Baughan United Kingdom 7 241 0.5× 9 0.0× 505 1.6× 140 0.6× 101 1.0× 9 864

Countries citing papers authored by Â. Fêde

Since Specialization
Citations

This map shows the geographic impact of Â. Fêde's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Â. Fêde with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Â. Fêde more than expected).

Fields of papers citing papers by Â. Fêde

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Â. Fêde. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Â. Fêde. The network helps show where Â. Fêde may publish in the future.

Co-authorship network of co-authors of Â. Fêde

This figure shows the co-authorship network connecting the top 25 collaborators of Â. Fêde. A scholar is included among the top collaborators of Â. Fêde based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Â. Fêde. Â. Fêde is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Fêde, Â., et al.. (2024). Antibody-Drug Conjugates in Breast Cancer: A Comprehensive Review of How to Selectively Deliver Payloads. Breast Cancer Targets and Therapy. Volume 16. 51–70. 10 indexed citations
2.
Caparica, Rafael, Marco Bruzzone, Elisa Agostinetto, et al.. (2021). Beta-blockers in early-stage breast cancer: a systematic review and meta-analysis. ESMO Open. 6(2). 100066–100066. 34 indexed citations
3.
Fêde, Â., Marina De Brot, Cynthia Aparecida Bueno de Toledo Osório, et al.. (2021). Malignant Phyllodes Tumor of the Breast: A Practice Review. SHILAP Revista de lepidopterología. 11(2). 205–215. 11 indexed citations
4.
Barroso‐Sousa, Romualdo, Rodrigo Ramella Munhoz, Milena Perez Mak, et al.. (2014). Activity and safety of sunitinib in poor risk metastatic renal cell carcinoma patients. International braz j urol. 40(6). 835–841. 2 indexed citations
5.
Miranda, Vanessa da Costa, Â. Fêde, Carlos Henrique dos Anjos, et al.. (2013). Neoadjuvant chemotherapy with six cycles of carboplatin and paclitaxel in advanced ovarian cancer patients unsuitable for primary surgery: Safety and effectiveness. Gynecologic Oncology. 132(2). 287–291. 69 indexed citations
6.
Saad, Everardo D., Emma Chen Sasse, Vanessa Costa Miranda, et al.. (2012). Formal Statistical Testing and Inference in Randomized Phase II Trials in Medical Oncology. American Journal of Clinical Oncology. 36(2). 143–145. 2 indexed citations
7.
Cruz, Felipe Melo, Daniel de Iracema Gomes Cubero, Patrícia Taranto, et al.. (2011). Gabapentin for the prevention of chemotherapy- induced nausea and vomiting: a pilot study. Supportive Care in Cancer. 20(3). 601–606. 29 indexed citations
8.
Miranda, Vanessa da Costa, et al.. (2011). Adverse Drug Reactions and Drug Interactions as Causes of Hospital Admission in Oncology. Journal of Pain and Symptom Management. 42(3). 342–353. 89 indexed citations
9.
Fêde, Â., et al.. (2010). Experience with The ABC Foundation School of Medicine Undergraduate Meeting. Revista da Associação Médica Brasileira. 56(3). 313–317. 6 indexed citations
10.
Fêde, Â., et al.. (2010). Doctor, how long?. European Journal of Cancer Care. 20(1). 50–55. 6 indexed citations
11.
Fêde, Â., et al.. (2010). Use of unnecessary medications by patients with advanced cancer: cross-sectional survey. Supportive Care in Cancer. 19(9). 1313–1318. 74 indexed citations
12.
Riechelmann, Rachel P., et al.. (2010). Use of unnecessary medications by terminally ill cancer patients.. Journal of Clinical Oncology. 28(15_suppl). 9073–9073.
13.
Miranda, Vanessa da Costa, et al.. (2009). Como consentir sem entender?. Revista da Associação Médica Brasileira. 55(3). 328–334. 16 indexed citations
14.
Fêde, Â., et al.. (2009). Importance of cancer among the Brazilian elderly population from 2000 to 2005. SHILAP Revista de lepidopterología.
15.
Fêde, Â., et al.. (2007). Multivitamins Do Not Improve Radiation Therapy-Related Fatigue. American Journal of Clinical Oncology. 30(4). 432–436. 30 indexed citations
16.
Fêde, Â., João Víctor Salvajoli, Gustavo Arruda Viani, et al.. (2007). Salvage radiotherapy for biochemical relapse after complete PSA response following radical prostatectomy: outcome and prognostic factors for patients who have never received hormonal therapy. Radiation Oncology. 2(1). 8–8. 9 indexed citations
17.
Paccagnella, A., G Cavaniglia, L. Loreggian, et al.. (2004). Randomized Phase III Trial of Neoadjuvant Chemotherapy in Head and Neck Cancer: 10-Year Follow-Up. JNCI Journal of the National Cancer Institute. 96(22). 1714–1717. 143 indexed citations
18.
Pucciarelli, Salvatore, Â. Fêde, Flavio Francini, et al.. (1996). Percutaneous Endoscopic Gastrostomy for Feeding. ORL. 58(5). 253–257. 4 indexed citations
19.
Paccagnella, Adriano, Antonio Orlando, C. Marchiori, et al.. (1994). Phase III Trial of Initial Chemotherapy in Stage III or IV Head and Neck Cancers: a Study by the Gruppo di Studio sui Tumori della Testa e del Collo. JNCI Journal of the National Cancer Institute. 86(4). 265–272. 329 indexed citations
20.
Marchiori, C., et al.. (1989). Normovolemic hemodilution in head and neck surgery. European Archives of Oto-Rhino-Laryngology. 246(5). 333–335. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026